Corporate Law Group

Corporate Law Group

Publications


Articles

The insolvency and bankruptcy code is not living up to its promise
Anubha Agarwal| CNBC TV 18 | 26-Feb-'19 |

Share

E-cigarettes: Regulation and not prohibition is the answer
Krishna Sarma| CNBC TV 18 | 15-Jan-'19 |

Share

Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
Krishna Sarma| CNBC TV 18 | 02-Jan-'19 |

Share

MJ Akbar vs #MeToo Movement: How defamation cases play out in India
Krishna Sarma| CNBC TV18 | 17-Oct-'18 |

Share

Clinical Trials in India
Krishna Sarma & Manisha Singh | FDLI Update magazine | October/November 2018 issue

Share

Why the one-woman director rule in companies is not enough for gender diversity
Anubha Agarwal | CNBC TV18 | 27-Aug-'18

Share

Why the new arbitration bill is much ado about nothing
Krishna Sarma | CNBC TV18 | 16-Aug-'18

Share

Assam NRC Final Draft: A Démarche on the Way Forward is Essential
Krishna Sarma | The Quint | 01-Aug-'18

Share

How sudden policy shifts are hurting development in the North-East
Krishna Sarma and Jayakrishnan KR | CNBC TV18 | 23-May-'18

Share

Monsanto ruling may hit innovation
Krishna Sarma | Hindu Business Line | 13-May-'18

Share

Of new drugs, safety and data exclusivity side effects
Krishna Sarma | Hindu Business Line | 18-Feb-'17

Share

Why cap prices of medical devices
Bhaskar Bhattacharya| The Financial Express | 18-Feb-'16

Share

Spurring R&D investment in medicine
Krishna Sarma | The Financial Express | 26-Nov-'15

Share

The real test lies in proper testing
Krishna Sarma | Hindustan Times | 07-July-'14 (Biosims)

Share

Raising the bar too high
Krishna Sarma | Financial Express | 3-Apr-'13

Share

Guidelines on Similar Biologics- a milestone for India
Rajashree Sharma | Pharmabiz | 4-Oct-'12

Share

Is Sobering Tone On India IP Laws An Early Signal Of Reconciliation By U.S.?
CLG | Elsevier Business Intelligence (PharmAsia) | 2-May-'12

Share

Insider Analysis From Corporate Law Group New Delhi On India’s Drug Pricing Regulations
Krishna Sarma, Bhaskar Bhattacharya | Elsevier Business Intelligence (PharmAsia)| 23-Apr-'12

Share

Food and Nutraceutical Regulations - Global Snapshot
Rajashree Sharma | FnBnews.com | 3-Jan-'12

Share

Food and Nutraceutical Regulations - Global Snapshot
Rajashree Sharma, FnBnews.com, 3-Jan-'12

Share

Change of management, infusion of capital and concession should happen in a time-bound manner
Avijit Roy, India Business Law Journal, Jan, 2012

Share

Adjudication under the Food Safety and Standards Act, 2006
Minakshi Sarma Dabas, FnBnews.com, 26-Dec-'11

Share

Regulatory approval procedure for biotech products
Rajashree Sharma, Pharmabiz, 20-Oct-'11

Share

Sharing accountability for SAEs
Riku Sarma & Manisha Singh, Express Pharma, 5-Aug-'11

Share

Indian nutraceuticals market – The road ahead
Rajashree Sharma, FnBnews, 30-Jun-'11

Share

New Food Regulatory Regime – Changes, Challenges and Way Ahead
Minakshi Sharma Dabas, The Centre for Science and Environment (CSE) newsletter, 21-Jun-'11

Share

CDSCO guidance Document on grant of licence for drugs import for test purposes
Manisha Singh, Chronicle Pharmabiz, 9-Jun-'11

Share

Watch your health food basket
Rajashree Sharma, The Hindu Business Line, 13-May-'11

Share

Free food body of corporate influence
Minakshi Sarma Dabas, Down To Earth, 15-Mar-'11

Share

India poised to be major global biotech player
Rajashree Sharma, Pharmabiz, 17-Feb-'11

Share

Stem cell research & regulatory framework
Rajashree Sharma, Pharmabiz, 27-Jan-'11

Share

SMEs can benefit from use of IPRs- IPR Expert Explains How!
Krishna Sarma, The New Indian Express, 4-Jan-'11

Share

Competition law and trade associations
Krishna Sarma, The Financial Express, 30-Dec-'10

Share

Public Funded Research In India: A Reckoner On Recent Legislative Actions
Rajashree Sharma, les Nouvelles-Journal of the Licensing Executives Society International (LESI), Dec 2010 issue

Share

Economics of biodiversity
Rajashree Sharma, The Financial Express, 17-Dec-'10

Share

India, a potential market for budding biosimilar cos
Rajashree Sharma, Pharmabiz.com, 25-Nov-'10

Share

Regulation to fuel biosimilars boom
Rajashree Sharma, The Economic Times, 18-Nov-'10

Share

How to ride the biosimilar wave
Rajashree Sharma, The Financial Express, 8-Nov-'10

Share

International standard RDP will provide the correct incentives to innovate
Krishna Sarma, Express Pharma, 15-Sep-'10

Share

Indian companies gain, NOT just MNCs
Krishna Sarma, The Economic Times, 6-Jan-'09

Share

Dams of North-East raise crucial concerns
Krishna Sarma, The Economic Times, 28-Aug-'08

Share

Indian companies also gain tremendously - not just MNCs
Krishna Sarma, The Economic Times, 6-Jan-'09

Share

Patent linkage to drug regulation will enhance R&D efficiency
Krishna Sarma, The Economic Times, 13-May-'08

Share

Give fiscal support to brownfield airport projects
Jayakrishnan, The Economic Times, 18-Feb-'08

Share

Environmental Degradation and its Protection - Legal Perspectives
Avijit Roy, LegalServiceIndia.com, 1-Feb-'08

Share

Unleash shackles on Import of Remanufactured Capital Goods
Jayakrishnan, The Hindu Business Line, 5-Sep-'07

Share

A Worrying Precedent - India Business Law
Ms. Krishna Sarma, Indian Business Law, 1-Sep-'07

Share

Trivial change may result in significant inventions
Krishna Sarma, The Economic Times, 8-May-'07

Share

Sequential' opposition delaying drug patents
Krishna Sarma, The Hindu Business Line, 3-Apr-'06

Share


Updates

RSS Business News


Updates

Practice Areas

Industry Verticals

Contact

  • F-21, Jangpura Extension, New Delhi-110014
  • +91-11-43621000 (100 Lines)
  • info@clgindia.com
  • www.clgindia.com

Corporate Law Group © 2021

CLG LOGO 2

Corporate Law Group

Disclaimer

As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I agree” below, the user acknowledges the following:

there has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website; 

The user wishes to gain more information about us for his/her own information and use;
the information about us is provided to the user only on his/her specific request and any information obtained or materials downloaded from this website is completely at the user’s volition and any transmission. The information provided under this website is solely available at your request for informational purposes only, should not be interpreted as soliciting or advertisement.